|
Market Closed -
NYSE
16:30:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 10.29 USD | +0.85% |
|
-1.53% | -30.24% |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
| 07-30 | Daxor Corporation Initiates Outpatient Blood Volume Analysis Program in Kansas | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -12.28x | 0.65x | 0x | 8.83x | - | 21.21x | 14.59% | 3.29B | |
| 13.26x | 1.01x | -0.16x | 12.05x | - | 14.32x | 7.59% | 3.21B | |
| Average | 0.49x | 0.83x | -0.08x | 10.44x | 17.77x | 11.09% | 3.25B | ||
| Weighted average by Cap. | 0.34x | 0.83x | -0.08x | 10.42x | 17.81x | 11.13% |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Sector Daxor Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
